Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery

The adaptation of existing antimalarial nanocarriers to new Plasmodium stages, drugs, targeting molecules, or encapsulating structures is a strategy that can provide new nanotechnology-based, cost-efficient therapies against malaria. We have explored the modification of different liposome prototypes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nanomedicine
Autores principales: Marques, Joana, Valle-Delgado, Juan José, Urbán, Patricia, Baró, Elisabet, Prohens, Rafel, Mayor, Alfredo, Cisteró, Pau, Delves, Michael, Sinden, Robert E., Grandfils, Christian, de Paz, José L., García-Salcedo, José A., Fernàndez-Busquets, Xavier
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5332526/
https://ncbi.nlm.nih.gov/pubmed/27720930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.09.010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares